Keep mercury blood pressure devices until new development is standard
This article was originally published in Clinica
Mercury-containing sphygmomanometers should remain available as a reference standard for the clinical validation of existing and future mercury-free blood pressure measurement devices. That is the view of the European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR).
You may also be interested in...
With hospitals throughout the EU short of urgently needed COVID-19 medical supplies, including respiratory equipment, there are ways for companies to sell and deliver their products quickly.
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.
Commission Provides Regulatory Advice For COVID-19 Medtech Sector Entrants Amid Counterfeit Concerns
A new European Commission guidance document explains the regulatory basics and emergency market entry criteria for new entrants to the devices sector amid the COVID-19 crisis.